139 related articles for article (PubMed ID: 36905668)
21. Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC).
Story E; Johnston DL; Bartels U; Carret AS; Crooks B; Eisenstat DD; Fryer C; Lafay-Cousin L; Larouche V; Wilson B; Zelcer S; Silva M; Brossard J; Bouffet E; Keene DL
J Neurooncol; 2017 Jul; 133(3):581-587. PubMed ID: 28508928
[TBL] [Abstract][Full Text] [Related]
22. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
[TBL] [Abstract][Full Text] [Related]
23. Nimotuzumab therapy in the treatment of pediatric central nervous system tumors: single-center experience.
Susam-Sen H; Varan A; Bajin İ; Göçmen R; Aydın B; Yalcin B; Kurucu N; Kutluk T; Bayhan T; Akyuz C
Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1769-1777. PubMed ID: 34151393
[TBL] [Abstract][Full Text] [Related]
24. Liposomal cytarabine for central nervous system embryonal tumors in children and young adults.
Partap S; Murphy PA; Vogel H; Barnes PD; Edwards MS; Fisher PG
J Neurooncol; 2011 Jul; 103(3):561-6. PubMed ID: 20859651
[TBL] [Abstract][Full Text] [Related]
25. [Germ cell and embryonal tumors].
Reith W; Mühl-Benninghaus R; Simgen A; Yilmaz U
Radiologe; 2014 Aug; 54(8):772-82. PubMed ID: 25119569
[TBL] [Abstract][Full Text] [Related]
26. Cost-Effectiveness Analysis of a Three-Drug Regimen Containing Bevacizumab for the Treatment of Recurrent Pediatric
Chen Z; Tian F; Chen X
Front Public Health; 2022; 10():914536. PubMed ID: 35719637
[TBL] [Abstract][Full Text] [Related]
27. [Irinotecan plus temozolomide in refractory or relapsed pediatric solid tumors].
Hernández-Marqués C; Lassaletta-Atienza A; Ruiz Hernández A; Blumenfeld Olivares JA; Arce Abaitua B; Cormenzana Carpio M; Madero Lopez L
An Pediatr (Barc); 2013 Aug; 79(2):68-74. PubMed ID: 23332825
[TBL] [Abstract][Full Text] [Related]
28. A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors.
Venkatramani R; Malogolowkin M; Davidson TB; May W; Sposto R; Mascarenhas L
PLoS One; 2013; 8(7):e68416. PubMed ID: 23894304
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study.
Grill J; Geoerger B; Gesner L; Perek D; Leblond P; Cañete A; Aerts I; Madero L; de Toledo Codina JS; Verlooy J; Estlin E; Cisar L; Breazna A; Dorman A; Bailey S; Nicolin G; Grundy RG; Hargrave D;
Neuro Oncol; 2013 Sep; 15(9):1236-43. PubMed ID: 23857707
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
31. Phase I study of bevacizumab plus irinotecan in pediatric patients with recurrent/refractory solid tumors.
Okada K; Yamasaki K; Tanaka C; Fujisaki H; Osugi Y; Hara J
Jpn J Clin Oncol; 2013 Nov; 43(11):1073-9. PubMed ID: 24002900
[TBL] [Abstract][Full Text] [Related]
32. Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor.
Wang J; Zhang L; Guo L; Que Y; Zhang Y; Sun F; Zhu J; Lu S; Huang J; Wu L; Cai R; Zhen Z; Zeng S; Zhang Y; Sun X
Front Oncol; 2021; 11():721564. PubMed ID: 34621673
[TBL] [Abstract][Full Text] [Related]
33. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
Cotter JA; Judkins AR
Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
[TBL] [Abstract][Full Text] [Related]
34. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Bevacizumab Combined with Other Therapeutic Regimens for Treatment of Recurrent Glioblastoma: A Network Meta-analysis.
Dongpo S; Zhengyao Z; Xiaozhuo L; Qing W; Mingming F; Fengqun M; Mei L; Qian H; Tong C
World Neurosurg; 2022 Apr; 160():e61-e79. PubMed ID: 34973444
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
37. NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.
Gilbert MR; Pugh SL; Aldape K; Sorensen AG; Mikkelsen T; Penas-Prado M; Bokstein F; Kwok Y; Lee RJ; Mehta M
J Neurooncol; 2017 Jan; 131(1):193-199. PubMed ID: 27770279
[TBL] [Abstract][Full Text] [Related]
38. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).
Rao S; Rajeswarie RT; Chickabasaviah Yasha T; Nandeesh BN; Arivazhagan A; Santosh V
Childs Nerv Syst; 2017 Nov; 33(11):1953-1959. PubMed ID: 28744687
[TBL] [Abstract][Full Text] [Related]
39. Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Sholler GLS; Bergendahl G; Lewis EC; Kraveka J; Ferguson W; Nagulapally AB; Dykema K; Brown VI; Isakoff MS; Junewick J; Mitchell D; Rawwas J; Roberts W; Eslin D; Oesterheld J; Wada RK; Pastakia D; Harrod V; Ginn K; Saab R; Bielamowicz K; Glover J; Chang E; Hanna GK; Enriquez D; Izatt T; Halperin RF; Moore A; Byron SA; Hendricks WPD; Trent JM
Genome Med; 2024 Feb; 16(1):28. PubMed ID: 38347552
[TBL] [Abstract][Full Text] [Related]
40. Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors.
Campen CJ; Dearlove J; Partap S; Murphy P; Gibbs IC; Dahl GV; Fisher PG
J Neurooncol; 2012 Nov; 110(2):287-91. PubMed ID: 22941430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
